Margaux Balduck

Ms. Margaux Balduck

Institute of Tropical Medicine Antwerp, Antwerp, Flanders, Belgium
+1

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
MBMargaux Balduck
Margaux Balduck
JLJolein Gyonne Elise Laumen
Jolein Gyonne Elise Laumen
SASaïd Abdellati
Saïd Abdellati
IBIrith De Baetselier
Irith De Baetselier
TBTessa de Block
Tessa de Block
CKChris Kenyon
Chris Kenyon
In addition to antimicrobial resistance, bacteria contain other mechanisms to survive antibiotic exposure such as tolerance, defined as the ability to slow metabolism by the extension of the lag phase without altering antimicrobial susceptibility. In a number of bacterial species, tolerance has been associated with treatment failure and infection chronicity and is found to precede and facilitate antimicrobial resistance. It is unknown if tolerance can be induced in Neisseria gonorrhoeae. In this study, we determined if tolerance to ceftriaxone (CRO) can be induced in N. gonorrhoeae and detected in clinical isolates. To induce tolerance, WHO P N. gonorrhoeae reference strain samples were grown under daily 3 h intermittent CRO exposure (10× the MIC), partitioned by overnight growth in GC broth. This cyclic exposure was performed for 7 consecutive days in sextuplicate, with two control cultures to which GC medium without antibiotics was added. To detect tolerance and assess CRO susceptibility, modified Tolerance Disc (TD) and Epsilometer tests were performed on isolates after each CRO exposure cycle. Additionally, this experiment was carried out on 18 clinical N. gonorrhoeae isolates. Tolerance was first detected after two CRO exposure cycles in five out of six samples. The phenotype differed per cycle with no clear pattern. No tolerance was found in control samples but was detected in 10 out of 18 clinical isolates. The present study is the first to demonstrate the induction of tolerance to CRO in N. gonorrhoeae through antibiotic exposure. In addition, tolerance to CRO was found in clinical samples.

26 June 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
MBMargaux Balduck
Margaux Balduck
ASAkim Strikker
Akim Strikker
ZGZina Gestels
Zina Gestels
SASaïd Abdellati
Saïd Abdellati
DBDorien Van Den Bossche
Dorien Van Den Bossche
SMSheeba Santhini Manoharan-Basil
Sheeba Santhini Manoharan-Basil
Background: Tolerance enables bacteria to survive intermittent antibiotic exposure without an increase in antimicrobial susceptibility. In this study, we investigated the presence of tolerance to three antimicrobials, ceftriaxone, azithromycin and ciprofloxacin, in clinical isolates and the WHO (World Health Organization) reference panel of Neisseria gonorrhoeae. Methods: We used the modified tolerance disk (TD test) to assess for tolerance to ceftriaxone, azithromycin and ciprofloxacin in 14 WHO reference strains and 62 N. gonorrhoeae clinical isolates—evenly divided between anorectal and urogenital infections. The isolates underwent a three-step incubation process wherein the isolates were exposed to an antibiotic disk for 20 h of incubation (Step I), followed by the replacement of the antibiotic disk with a nutrient disk for overnight incubation (Step II) and additional overnight incubation with extra nutrients (Step III). Results: A total of 4 of the 62 clinical anorectal isolates and none of the urogenital isolates exhibited tolerance to azithromycin (p = 0.033). Tolerance to ceftriaxone and ciprofloxacin was observed in eight and four isolates, respectively, with no difference between infection sites. Tolerance was also detected in 8 (K, M, N, O, P, U, V, W) out of the 14 WHO reference strains, with varying patterns of tolerance to ceftriaxone (n = 8), ciprofloxacin (n = 2) and azithromycin (n = 1). Conclusions: This study identified ceftriaxone, azithromycin and ciprofloxacin tolerance in clinical and WHO reference N. gonorrhoeae isolates. Azithromycin tolerance was more common in anorectal than urogenital infections.

7 March 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
SMSheeba Santhini Manoharan-Basil
Sheeba Santhini Manoharan-Basil
MBMargaux Balduck
Margaux Balduck
SASaïd Abdellati
Saïd Abdellati
ZGZina Gestels
Zina Gestels
TBTessa de Block
Tessa de Block
CKChris Kenyon
Chris Kenyon
Antibiotic tolerance is associated with antibiotic treatment failure, and molecular mechanisms underlying tolerance are poorly understood. We recently succeeded in inducing tolerance to ceftriaxone (CRO) in an N. gonorrhoeae reference isolate. In a prior in vitro study, six biological replicates of WHO P strains were exposed to CRO (10× the MIC) followed by overnight growth, and tolerance was assessed using a modified Tolerance Disc (T.D.) test. In the current study, we characterized the mutation profile of these CRO-tolerant phenotypes. The whole genome was sequenced from isolates from different replicates and time points. We identified mutations in four genes that may contribute to ceftriaxone tolerance in N. gonorrhoeae, including a mutation in the enolase (eno) gene that arose independently in three lineages.

12 March 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MBMargaux Balduck
Margaux Balduck
ASAkim Strikker
Akim Strikker
ZGZina Gestels
Zina Gestels
SASaïd Abdellati
Saïd Abdellati
DBDorien Van Den Bossche
Dorien Van Den Bossche
SMSheeba Santhini Manoharan-Basil
Sheeba Santhini Manoharan-Basil
Background: Bacteria can survive antibiotic exposure by mechanisms like tolerance without a shift in antimicrobial susceptibility. In this study, we investigated the presence of tolerance to three antimicrobials, ceftriaxone (CRO), azithromycin (AZM), and ciprofloxacin (CIP), in clinical isolates and WHO reference panel of N. gonorrhoeae and explored the prevalence between urogenital and anorectal infection sites. Methods: We examined 66 N. gonorrhoeae clinical isolates, evenly divided between anorectal and urogenital infection sites, using a modified tolerance disk (TD test) for three antibiotics. The isolates underwent a three-step incubation process wherein the isolates were exposed to an antibiotic disc for 20 hours of incubation (Step I), followed by the replacement of the antibiotic disc with a nutrient disc for overnight incubation (Step II) and additional overnight incubation with extra nutrients (Step III). Results: Four isolates were lost due to contamination. Of 62 clinical isolates, 7 exhibited tolerance to AZM, with 6 from anorectal and 1 from urogenital sites (p = 0.0496). Tolerance to CRO was observed in 11 isolates, which was significantly associated with the infection site, with 9 from the anorectum, and 2 from the urogenital site being tolerant (p = 0.02). Tolerance to CIP was found in 11 isolates, but was not significantly associated with the infection site. Tolerance was also detected in 8 (K, M, N, O, P, U, V, W) out of the 14 WHO (World Health Organization) reference strains, with varying patterns of tolerance to CRO (n=8), CIP (n=2) and AZM (n=1). Conclusion: This study identified CRO, AZM, and CIP tolerance in clinical Neisseria gonorrhoeae isolates. Significant variations in tolerance proportions between anorectal and urogenital infection sites, particularly for CRO, were observed. Additionally, tolerance was detected in WHO reference strains.

24 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SMSheeba Santhini Manoharan-Basil
Sheeba Santhini Manoharan-Basil
MBMargaux Balduck
Margaux Balduck
ZGZina Gestels
Zina Gestels
SASaïd Abdellati
Saïd Abdellati
TBTessa de Block
Tessa de Block
CKChris Kenyon
Chris Kenyon
Background Antibiotic tolerance is associated with failure of antibiotic treatment and accelerates the development of antimicrobial resistance. The molecular mechanisms underlying antimicrobial tolerance remain, poorly understood. In some instances, tolerant bacteria can slow metabolism by extending the lag phase without altering antimicrobial susceptibility. We recently induced ceftriaxone (CRO) tolerance in the N. gonorrhoeae reference strain WHO P. In the current study, we characterized the transcriptomic profiles of these CRO-tolerant phenotypes. Methods To induce tolerance, WHO P strains were grown under three-hour intermittent CRO exposure (10× the MIC), followed by overnight growth in GC broth for seven consecutive days, with cultures maintained in sextuplicate. Two control cultures were maintained without CRO exposure. The tolerance and CRO susceptibility of the isolates were assessed using a modified Tolerance Disc (TD) test. Total RNA was isolated from tolerant isolates (n=12) and control (n = 3) strains, followed by Ribo depletion. Library preparation was carried out using the Stranded TruSeq RNA library preparation kit. Sequencing was performed on a NextSeq6000, v2. 1 × 150 bp (Illumina Inc., San Diego, CA, USA), and data analysis was performed using the CLC Genomics Workbench v22 (clcbio, Denmark). Results Transcriptomic analysis revealed no differentially expressed genes at the first time point that was assessed (after 1 day of CRO exposure). However, after 3 days of CRO exposure, 13 genes were found to be significantly downregulated, including tRNA-Ser (C7S06_RS03100) and tRNA-Leu (C7S06_RS04945) and ribosomal RNA genes (16S and 23S rRNA). Following 7 days of exposure, 51 genes were differentially expressed with most downregulated, such as SecB (Protein-export chaperone SecB) and tRNA-Ser (C7S06_RS01850) and the 16S and 23S ribosomal RNA genes. Conclusions The development of CRO-tolerance in N. gonorrhoeae was associated with the downregulation of various ribosomal genes and associated genes, reflecting a potential mechanism for bacterial survival under antibiotic stress.